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OBJECTIVE: To develop a scoring system based on clinical findings to assist pediatricians in the diagnosis of William syndrome
and to delineate when the fluorescent in-situ hybridization test to detect the microdeletion at 7q11.23 may be needed.
METHODS: The fluorescent in-situ hybridization test was performed on 20 patients presenting William syndrome suggestive
clinical features. Eleven studies were selected from the literature in which there were 2 groups: patients with positive or negative
fluorescent in-situ hybridization tests. Forty-two clinical characteristics were compared to those reported in the literature to
determine which ones were associated with the affected patients (ie, bearing deletions) using meta-analysis. The 2-tailed Fisher
exact test were used so that the frequency of findings observed in fluorescent in-situ hybridization positive and fluorescent in-situ
hybridization negative patients could be compared in the present study together with the patients from the literature. We developed
a scoring system based on clinical findings and their significant associations with patients with positive fluorescent in-situ
hybridization tests. From the mean and standard-deviation values of the data from our patients, we determined the cut-off score
that that indicated the need for a fluorescent in-situ hybridization test to confirm diagnosis.
RESULTS: Seventeen patients were fluorescent in-situ hybridization positive, and 3 were fluorescent in-situ hybridization negative.
The more discriminative findings among fluorescent in-situ hybridization positive patients were the following: typical facies, low
birth weight, feeding difficulties, constipation, supravalvar aortic stenosis, mental retardation, and friendly personality. The
distribution of the points among the 20 patients ranged from 19 to 28 points with a mean value of 23.3 out of a possible total of 31
points. The cut-off score that indicated the need for a fluorescent in-situ hybridization test was 20.
CONCLUSIONS: Our scoring system enables physicians to differentiate between those individuals who can be reliably diagnosed
as having Williams syndrome solely from the clinical findings and those who need to undergo fluorescent in-situ hybridization
testing for a correct diagnosis.
KEYWORDS: Williams syndrome. Chromosome 7. In-situ hybridization. Elastin gene.
INTRODUCTION
Williams syndrome (WS), also known as Williams-
Beuren syndrome (WBS), is rare (1:20,000 to 1:50,000 live
births)1 and is characterized by multiple anomalies includ-
ing typical facial dysmorphisms, congenital heart defects,
growth deficiency, mental retardation (MR), and occasion-
ally infantile hypercalcemia.2,3 Williams syndrome is con-
sidered a segmental aneusomy due to a hemizygous dele-
tion of a contiguous gene at the long arm of chromosome
7 (7q11.23).4,5 Most individuals with WS (99%) have a 1.5
megabase deletion in 7q11.23 encompassing the elastin
gene (ELN) and 25-35 other genes,5,6, all of which is de-
tectable by fluorescent in situ hybridization (FISH).7,8
Diagnosis of WS is made by clinical evaluation, usu-
ally during infancy, when the typical facial characteristics
become more evident, becoming recognizable as early as
4 months of age.9 The FISH test is useful for confirming
the diagnosis because the broad phenotypic spectrum hin-
ders the making of a diagnosis, especially in the first year
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of life. This study is part of an institutional project which
aims at establishing the genetic basis if prevalent congeni-
tal anomalies10 and its purpose was to develop a scoring
system based on objective clinical findings of WS patients
to assist general pediatricians in making a clinical diagno-
sis of the disease.
METHODS
Twenty patients who presented suggestive clinical fea-
tures of WS were included. The mean age at the time of
the diagnosis was 5.9 years. Karyotypes of lymphocytes
from a peripheral blood sample were evaluated using
Giemsa-Trypsin-Giemsa banding. Hemizygosity for the
elastin gene was identified using FISH (fluorescence in-situ
hybridization) with the LSI Williams Syndrome Region
DNA probe (VYSIS®) (Figures 1, 2, and 3a,b) as described
elsewhere.11
We also performed a meta-analysis of 11 studies se-
lected from the literature to establish the clinical features
that are associated with FISH-positive patients; these stud-
ies were those of Borg et al (1995),12 Brewer et al (1995),13
Kotzot et al (1995),14 Lowery et al (1995),15 Nickerson et
al (1995),16 Joyce et al (1996)17, Perez Jurado et al (1996),18
Brondum-Nielsen et al (1997),19 Elcioglu et al (1998);20
Mila et al (1999),21 and Beust et al (2000).22 A total of 597
patients with WS were analyzed (including 20 patients of
our sample), and among them, 361 individuals had the
microdeletion of the ELN locus. We selected works that
were similar to our study, ie, with the frequency of clini-
cal features being categorized into 2 groups: individuals
that were FISH-positive or FISH-negative.
Forty-two clinical characteristics were analyzed from
577 patients as follows: low birth weight, feeding difficul-
ties, failure to thrive, vomiting, obstipation, bitemporal nar-
rowing, broad forehead, periorbital fullness, flat malar, full
cheeks, low nasal root, short upturned nose, long philtrum,
wide mouth, thick lips, small jaw, dental anomalies, hoarse
voice, strabismus, stellate iris pattern, supravalvular aortic
stenosis (SVAS), pulmonary artery stenosis, mitral valve
prolapse, aortic coarctation, non-SVA congenital heart dis-
ease, umbilical/inguinal hernia, kidney anomalies, arterial
hypertension, hypercalcemia, joint contractures, fifth fin-
ger clinodactyly, hypoplastic nails, short stature, micro-
cephaly, hypotonia, developmental delay, hyperacusis, men-
tal retardation, overfriendliness, hyperactivity, anxiety, and
loquaciousness.
We used the 2-tailed Fisher exact test to compare the
frequencies of WS clinical characteristics presented by our
patients that were FISH-positive and Fish-negative as well
Figure 1 - Region 7q11.23 on the long arm of chromosome 7 and probe
VYSIS® LSI Williams Syndrome
Figure 2 - Chromosome 7 ideogram: regions of probe hybridization
Figure 3 - a: Picture of FISH test for WS demonstrating metaphase with 2
red signals (elastin gene) and 2 green signals (markers of chromosome 7),
therefore without elastin gene deletion (FISH-negative patient). b: Picture
of FISH test for WS demonstrating metaphase with 2 green signals (markers
of chromosome 7) and only 1 red signal (elastin gene); therefore, with
deletion of the elastin gene (FISH-positive patient).
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as those reported in the literature using meta-analysis.22 We
considered an association between WS clinical findings and
the presence of a microdeletion at elastin gene locus to be
statistically significant when P < 0.001.
The level of significance (α = 0.05) was adjusted us-
ing Bonferroni’s correction for multiple comparisons. This
was accomplished by dividing the significance level (α =
0.05) by the total number of pair-wise comparisons of the
presence of the microdeletion with the clinical character-
istics (42). Using such a stringent significance level reduces
the chances of a type I error or the Bonferroni’s effect.
Bonferroni’s correction is used when multiple dependent
or independent statistical tests are performed simultane-
ously. Although a certain alpha value may be appropriate
for each individual comparison, it is not appropriate for the
set of all comparisons. In order to avoid a large number of
false positives, the alpha values needs to be lowered to ac-
count for the numbers of comparisons being performed.23,24
We developed a scoring system (Table 1) based on the
clinical findings for which meta-analysis showed a signifi-
cant association (P < 0.001) with FISH-positive tests. We
also included clinical findings with the significance level
close to the adjusted “α” using Bonferroni’s correction in
order to have a larger number of objective variables, which
facilitates the WS diagnosis for general pediatricians. The
scoring was done as follows: 3 points for the clinical find-
ings with a significance level under P < 0.001, 2 points
for characteristics with P close (although not statistically
significant) to the adjusted “α” using Bonferroni’s correc-
tion; and 1 point for the features with P close to the α with-
out using correction for Bonferroni’s error (ie, α = 0.05),
which would have been significant if P had not been cor-
rected. We decided to exclude some features that might
have been included in the scoring system exclusively by
these criteria, because these features cannot be objectively
characterized. The Kolmogorov-Smirnov method was used
to check whether the values obtained by the scoring sys-
tem presented a Gaussian distribution.23 We correlated the
scores with the percentiles, based on the means and stand-
ard-deviations of the data collected from the 20 patients
of the present study.
RESULTS
The GTG-stained karyotype was normal in all 20 pa-
tients. The deletion of the elastin gene was found in 17 out
of 20 patients. In both groups, the main complaints were
the failure to thrive and feeding difficulty. Constipation was
observed in 59% of FISH-positive patients. All patients pre-
sented typical facies (Figure 4a, b). Dental anomalies,
hoarse voice, strabismus, stellate pattern of the iris, and reti-
nal vessel tortuosity were observed only in FISH-positive
Table 1 - Phenotype scoring system of the present work
Characteristics Points
Low birth weight 3
Feeding difficulties 3
Obstipation 3
Typical face 3
SVAS 3
Mental deficiency 3
Overfriendliness 3
Strabismus 2
Developmental delay 2
Failure to thrive 1
Non-SVAS congenital heart disease 1
Arterial hypertension 1
Joint contractures 1
Hyperacusis 1
Hypoplastic nails 1
Total 31
SVAS = supravalvular aortic stenosis
Figure 4a - Two patients (cases 1 and 2) with typical craniofacial features
of WS at 9 years of age.
Figure 4b - Two patients (cases 1 and 2) of WS at 19 years of age. The face
has become more elongated, the supraorbital ridges are more prominent,
and the lips have thickened. Both patients showed premature wrinkling of
the skin.
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patients. Cardiac abnormalities were diagnosed in all pa-
tients who were FISH-positive except 1, but they were ab-
sent in FISH-negative patients. The most frequent cardiac
defects were supravalvar aortic stenosis (SVAS), branch
pulmonary stenosis, and mitral valve prolapse. Addition-
ally, inguinal and umbilical hernias were detected in 41%
of FISH-positive patients and in 1 FISH-negative individual.
Renal anomalies were diagnosed in 5 /17 FISH-positive
patients and in 1 individual from the FISH-negative group.
Hypertension was diagnosed in 3 patients with genomic
deletions and in none of the patients without deletions. Al-
though hypercalcemia was not observed in our sample, in-
termittent hypercalciuria was detected in 4 out of 17 FISH-
positive patients and in 2 out of the 3 FISH-negative ones.
All patients presented hypotonia, delayed psychomotor de-
velopment, and motor uncoordination. Hyperacusia was
found in 59% of the FISH-positive patients and in none of
the FISH-negative group. Mental retardation (MR) and the
friendly personality occurred in 95% of all patients, ie, in
all patients with genomic deletions and in 2 of the 3 pa-
tients without deletions.
The details of the scoring system are as follows (see
also Table 1):
• The occurrence of typical facial dysmorphisms (bitem-
poral narrowing, broad forehead, periorbital fullness,
full cheeks, short upturned nose, long philtrum, wide
mouth, thick lips), failure to thrive, feeding difficulties,
constipation at infancy, dental anomalies, SVAS, MR,
and friendly personality were significantly more fre-
quent (P < 0.001) in the group with genomic deletions
than in the group without deletions; these characteris-
tics were assigned a score of 3.
• Strabismus, low nasal root, flat malar, and developmen-
tal delay showed significant association with genomic
deletions by univariate analysis at α = 0.05. The P val-
ues were close to the adjusted alpha value when using
Bonferroni’s correction; these characteristics were as-
signed a score of 2.
• Failure to thrive, non-SVAS congenital heart disease,
arterial hypertension, joint contractures, hyperacusis,
and hypoplastic nails showed a significant association
on univariate analysis at α = 0.05, but the P values were
closer to the α value than the value corrected for
Bonferroni’s error; these characteristics were assigned
a score of 1.
Attributing the score according to the values described,
the total scores in the 17 FISH-positive patients ranged
from 19 (case 1) to 28 points (cases 8 and 13) out of a pos-
sible total score of 31. The scores in the 3 FISH-negative
patients were 12 (case 6), 15 (case 9), and 16 (case 16).
(Table 2 shows the individual scoring for our sample). The
mean value of the distribution curve of total points from
our patients was 23.3 (median 24) and the standard devia-
tion was 2.8. The 95% confidence interval of the mean was
17.8 (lower limit) to 24.7 (upper limit).
The 25 percentile of the score curve distribution was
18 points. To increase the accuracy of the scoring system,
we elected to establish the cut level at 20 points because
this value was between the 10 and 15 percentiles of the
Gaussian curve. Thus, the probability of a patient with a
value equal or higher than 20 points having a negative FISH
test would be low in our scoring system. Therefore, the
FISH test would be indicated for individuals suspected of
having WS, but having a total score of less than 20 points.
Table 2 - Phenotype scoring system of the present work applied with our 20 patients
Patients
Characteristics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Low birth weight - + + - - - + + - - + - + + + - + - - +
Feeding difficulties - + + + + + + + + + + + + - + + - + + +
Obstipation - - + - + - - + - + - + + + - - + + - +
Typical facies + + + + + + + + + + + + + + + + + + + +
SVAS + - + + - - + + - + + + + + + - - - + +
Mental deficiency + + + + + - + + + + + + + + + + + + + +
Overfriendliness + + + + + - + + + + + + + + + + + + + +
Strabismus - - - - - - + + - + - + + - + - + + + -
Developmental delay + + + + + + + + + + + + + + + + + + + +
Failure to thrive + + + + + + + + + + + + + + + + + + + +
Non-SVAS congenital heart disease - + - - + - - - - - - - - - - - + + - -
Arterial hypertension + - - - - - - - - - + - - + - - - - - -
Joint contractures + - - - - - - + - - - - - + - - - - - -
Hyperacusis + + + + + - + + - + + + + + - + + + + +
Hypoplastic nails + + - - - - - - - - - - + - + - + - - -
Total 19 21 25 19 20 12 24 28 15 24 23 24 28 24 24 16 23 22 21 27
SVAS= supravalvular aortic stenosis
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DISCUSSION
The proportion of the FISH-positive patients and FISH-
negative ones in the present work and the patients from the
literature used in performing meta-analysis are listed in
Table 3. We observed that in those works in which the fre-
quency of FISH-positive tests was low in comparison with
the majority of the studies, there was not a strict clinical
criterion for carrying out the FISH test. Joyce et al (1996)17
performed FISH on a series of 52 patients divided into 3
groups: 23 classical WS individuals; 22 atypical patients
with suspected WS; and 7 patients with isolated SVAS and
peripheral pulmonary stenosis. In the classical WS group,
22/23 (96%) had a microdeletion at the ELN locus. In the
suspected WS group 2/22 (9%) patients were found with
the microdeletion. Among 7 patients with isolated SVAS
and peripheral pulmonary stenosis, the FISH test was posi-
tive in only 1/7 (14%) individual with SVAS. In the sam-
ple of Brondum-Nielsen et al,19 19/24 FISH-positive pa-
tients with suspected WS had typical manifestations of WS.
None of the 20 FISH-negative individuals presented typi-
cal features of WS, and FISH was carried out due to the
developmental delay and the presence of some suggestive
characteristics of WS.
The 9 characteristics (low birth weight, feeding diffi-
culties, obstipation during infancy, typical facial features,
dental anomalies, hoarse voice, SVAS, MR, and friendly
personality) that showed a significant difference between
FISH-positive patients and FISH-negative ones are classi-
cal features of WS.7,8 These characteristics had been de-
scribed before the discovery of the microdeletion at
7q11.23.2,3
Low birth weight is attributed to intra-uterine growth
retardation, which was found for most FISH-positive pa-
tients of the studies selected by us for meta-analysis. Feed-
ing difficulties and obstipation were also present with in-
creased frequency in FISH-positive individuals from the
selected studies, and these are also commonly observed
complications associated with hypercalcemia during in-
fancy.9 However, hypercalcemia did not show a significant
difference between FISH-positive patients and FISH-nega-
tive ones in the meta-analysis because it has been docu-
mented in the general population at a low frequency.
Although the typical facial features were presented by
most of the individuals with suspicion of WS, this charac-
teristic was discriminating between patients bearing
microdeletion. We attribute this fact to some investigations
that had carried out FISH testing in a great number of pa-
tients without the facial dysmorphisms characteristic of
WS. Most of these individuals presented developmental
delay, MR, or hypercalcemia and some of the 11 facial fea-
tures that comprise the typical facial aspects of WS.
Supravalvar aortic stenosis was significantly associated
with microdeletion because the frequency of this cardiac
defect was very low in the large number of FISH-negative
patients. The frequency of hoarse voice in FISH-negative
patients was very low in the studies of Joyce et al,17 Mila
et al,21 and Beust et al22 and was absent in FISH-negative
patients in the study of Borg et al12 and in our sample.
There are 4 phenotype scoring systems for WS in the
literature. Preus (1985)26 studied 52 patients with a clini-
cal suspicion of WS and elaborated a detailed system based
on 50 clinical features, most of them consisting of minor
facial dysmorphisms and analyses of dermatoglyphics.
Lowery et al (1995)8 developed a phenotype scoring sys-
tem based on 6 clinical findings of 110 patients with WS
having microdeletion at 7q11.23 confirmed by the FISH
test. The patients with 4 to 10 points in this scoring sys-
tem were thought to have “classic WS” and those with
points between 0 and 3 were considered to be “uncertain”
as to having a WS diagnosis.
We did not use the Preus score for our sample because
of the complexity and the presence of several subjective
characteristics. And the phenotype scoring system proposed
by Lowery et al did not discriminate between typical and
atypical patients of our sample because the total score of
FISH-positive and -negative patients was classified in the
same category as the classic WS phenotype.
A clinical scoring system for WS based on a study of
107 patients with WS confirmed by the FISH test has been
proposed (The Health Care Supervision for Children with
Williams syndrome (2001)27 from the Committee on Ge-
netics of American Academy of Pediatrics). This scoring
system is divided into 7 items: growth, behavior, develop-
Table 3 - Frequency of patients with Williams syndrome
that were FISH-positive and FISH-negative from the
literature, and for our patients
Author (year) Positive Negative
FISH FISH Total
Borg et al (1995) 8 (80%) 2 (20%) 10 (100%)
Kotzot et al (1995) 22 (75%) 7 (25%) 29 (100%)
Nickerson et al (1995) 39 (91%) 7 (9%) 43 (100%)
Lowery et al (1995) 110 (96%) 4 (4%) 195 (100%)
Joyce et al (1996) 24 (53%) 21 (47%) 45 (100%)
Brewer et al (1996) 16 (94%) 1 (6%) 17 (100%)
Perez Jurado et al (1996) 61 (94%) 4 (6%) 65 (100%)
Brondum-Nielsen et al (1997) 24 (54%) 20 (46%) 44 (100%)
Elçioglu et al (1998) 14 (80%) 2 (20%) 16 (100%)
Mila et al (1999) 28 (45%) 41(55%) 69 (100%)
Beust et al (2000) 15 (34%) 29 (66%) 44 (100%)
Sugayama et al (2007) 17 (85%) 3 (15%) 20 (100%)
Total 378 (63%) 141 (24%) 97 (100%)
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ment, facial features, cardiovascular problems, connective
tissue abnormality, and calcium studies.
The early diagnosis of WS is essential for adequate
management of cardiovascular, renal and urinary28 compli-
cations, including risk of sudden death.29,30 Considering the
variability of WS expression, we developed a simplified
scoring system with objective clinical features to facilitate
the clinical diagnosis for general pediatricians who are not
familiar with WS.
Thus, according to Table 1, the presence of features re-
sulting in 20 points is strongly suggestive of WS, while total
points below this value would indicate the need to carry
out the FISH test to establish the appropriate diagnosis.
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RESUMO
Sugayama SMM, Leone C, Chauffaille M de LLF, Okay
TS, Kim CA. Síndrome de Williams: proposta de sistema
de pontuação para diagnóstico clínico. Clinics.
2007:62(2):159-66.
OBJETIVOS: Desenvolver um sistema de pontuação
(Score) baseado nos achados clínicos para auxiliar os pe-
diatras no diagnóstico clínico da Síndrome de Williams-
Beuren e na indicação do teste de hibridização in situ por
fluorescência para detectar a microdeleção em 7q11.23.
MÉTODOS: O teste de hibridização in situ por fluores-
cência foi feito em 20 acometidos pela Síndrome de
Williams-Beuren, nos quais 42 achados clínicos foram es-
tudados. Para estabelecer quais desses achados estariam
associados ao teste de hibridização in situ por fluorescência
positivo, realizou-se uma metanálise com 11 trabalhos da
literatura em que havia dois grupos, hibridização in situ por
fluorescência positivo e negativo. As freqüências dos acha-
dos presentes nos indivíduos fluorescência positivo e
fluorescência negativo neste estudo foram comparadas em
conjunto com os pacientes da literatura através do teste exa-
to de Fisher. Elaboramos um sistema de pontuação (score)
baseado nos achados que mostraram correlação significante
(p<0,001) para os pacientes hibridização in situ por
fluorescência positivo. Determinamos os valores correspon-
dentes aos percentis baseados na média e desvio-padrão,
calculados a partir dos 20 pacientes do presente trabalho.
RESULTADOS: Dezessete pacientes foram hibridização
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in situ por fluorescência positivo e três, negativo. Os acha-
dos mais discriminativos nos hibridização in situ por
fluorescência positivo (3 pontos no score) foram: fáceis tí-
pico, baixo peso ao nascimento, dificuldades alimentares,
obstipação, estenose aórtica supravalvar, deficiência men-
tal e personalidade amigável. A distribuição dos valores
entre os 20 pacientes variou de 19 a 28 pontos com uma
média de 23,3 pontos.
CONCLUSÕES: O score elaborado permitiu propor o
valor de 20 pontos para a indicação do teste de hibridização
in situ por fluorescência nos pacientes com suspeita clínica
de Síndrome de Williams-Beuren.
UNITERMOS: Síndrome de Williams-Beuren. Cromos-
somos humanos par 7. Hibridização in situ. Gene da
elastina.
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